CORT

#1301
Corcept Therapeutics Inc.
35.7000
+3.13%
セクター:
ベース:
利益通貨:
日中レンジ
35.7000
35.7000
1年のレンジ
28.6601
89.0000
1日の変化
+3.13%
月次変化
-22.83%
6か月変化
-51.34%
1年の変化
-51.34%
以前の終値
34.6150
Open
35.7000
Bid
Ask
Low
35.7000
High
35.7000
ボリューム
111
Open full chart

Financials

Overview 明細書 Statistics Dividends
Quarterly Annual
  • Market Capitalization 3.7079 B
  • Employee 500
  • Founded 1998
  • CEO N/A
  • Website www.corcept.com
  • Headquarter Delaware, United States
  • FIGI BBG000BKJG33
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
42.44
Price to sales ratio
5.48
Dividends per share
—
Dividend yield %
—

Corcept Therapeutics Incorporated

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

ニュース